BSE Ltd. Share Price

Emcure Pharmaceuticals : Penalty Orders ₹57.74 Crore

Emcure Pharmaceuticals Limited has informed stock exchanges (NSE: EMCURE / BSE: 544210) regarding regulatory orders received from the Income Tax Department. The disclosures, submitted pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, outline an aggregate penalty exceeding ₹57.73 crore spanning seven financial years. Key HighlightsTotal Financial Impact: Aggregate penalty imposed stands at ₹57,73,96,732. Applicable Assessment Period: Financial Years 2014-15 to 2020-21 (Assessment Years 2015-16 to 2021-22). Adjudicating Authority: Deputy Commissioner of Income Tax, Central Circle 2(1) – Pune. Dispute Timeline: Litigation originally initiated on December 27, 2023. Company Response: Emcure is evaluating legal remedies and intends to file an appeal before the Appellate Authority.

See More

Sterlite Technologies Secures ₹11,400 Crore Long-Term Deal

d. (STL) has signed a long-term supply agreement valued at approximately ₹11,400 crore ($1.2 billion) with an international hyperscale partner for optical connectivity products, with the arrangement extending through 2030. 📊 Key Highlights 🔹 Deal Size: ~₹11,400 crore 🔹 Contract Value: $1.2 billion 🔹 Duration: Through 2030 🔹 Products: Optical connectivity solutions 🔹 Client: International hyperscale partner 🔹 Focus Area: AI & Data-Centre Infrastructure The agreement offers STL long-term revenue visibility in the rapidly developing AI and data-centre infrastructure space, where hyperscale operators are investing in high-capacity fibre and advanced optical connectivity networks. 📌 Nivesh Research Insight: The deal enhances STL’s presence in the expanding AI and data-centre connectivity market. Investors should monitor execution, order conversion, margins and AI/data-centre capex trends to gauge the potential contribution to future business growth. #CapitalInvestoResearch #STL #SterliteTechnologies #AI #DataCentre #OpticalFiber #DigitalInfrastructure #Technology #StocksInFocus #StockMarket #NSE #BSE

See More

Sterlite Technologies Secures ₹11,400 Cr Optical Deal

. (STL) has entered into a long-term supply agreement worth approximately ₹11,400 crore ($1.2 billion) with an international hyperscale partner for optical connectivity products, with supplies expected to continue through 2030. 📊 Key Highlights 🔹 Deal Value: ~₹11,400 crore 🔹 Contract Value: $1.2 billion 🔹 Tenure: Through 2030 🔹 Products: Optical connectivity solutions 🔹 Customer: International hyperscale partner 🔹 Theme: AI & Data-Centre Infrastructure The agreement provides STL with multi-year business visibility in the rapidly expanding AI and data-centre infrastructure segment, where hyperscale operators require high-capacity fibre and optical connectivity network: The contract strengthens STL’s positioning in the growing AI and data-centre connectivity ecosystem. Investors should track execution, order conversion, margin performance and the pace of AI/data-centre capital expenditure to assess the deal’s impact on future growth. #CapitalinvestoResearch #STL #SterliteTechnologies #AI #DataCentre #OpticalFiber #DigitalInfrastructure #Technology #StocksInFocus #StockMarket #NSE #BSE

See More

Sarthak Metals Ltd (SMLT) surged nearly 20% today

Sarthak Metals Ltd (SMLT) surged nearly 20% today, closing around ₹74.82 on BSE and ₹74.18 on NSE, despite weak Q2 FY26 results showing a 28% drop in net profit and a 21% decline in revenue. The rally appears driven by short-term momentum rather than fundamentals. 📊 SMLT Q2 FY26 Results (Quarter ended Sep 2025) Revenue: ₹36.31 Cr (↓21.45% QoQ, ↓20.60% YoY) Operating Profit: ₹0.93 Cr (↓13.17% QoQ) Net Profit (PAT): ₹0.76 Cr (↓28.42% QoQ, ↓8.13% YoY) Operating Margin: 2.56% EPS: ₹0.57 (↓25.97% QoQ) 📈 Share Price Performance (1 Oct 2026) BSE Close: ₹74.82 (+20.00%) NSE Close: ₹74.18 (+19.99%) Day Range: ₹66.00 – ₹74.82 52-Week Range: ₹56.65 – ₹121.00 Market Cap: ~₹102 Cr P/E Ratio: 17.5 (slightly above sector average of 16.65) Debt-to-Equity: 0.05 (low leverage)

See More

Jio Financial infuses Rs 320 crore into insurance JV

Jio Financial Services Limited (NSE: JIOFIN) said on September 30, 2026, that it has invested Rs 320.05 crore in its general insurance joint venture, Jio Allianz General Insurance. Jio Financial Services and its JV partner Allianz Europe B.V. each subscribed to 32 crore equity shares of Rs 10 each in Jio Allianz General Insurance through a rights issue, taking the combined fresh infusion to Rs 640.10 crore. The proceeds will fund the insurance venture's business operations. With this round, Jio Financial's cumulative investment in the 50:50 JV stands at Rs 375 crore. The company said the transaction is a related party deal done at arm's length, with no interest from promoter or group companies. Jio Financial Services shares closed at Rs 216.60 on the BSE on September 30, down 0.6% on the day. The stock has traded in a 52-week range of roughly Rs 212 to Rs 317, and current levels are close to the lower end of that band. Market cap stands near Rs 1.4 lakh crore. The stock is trading well below the midpoint of its 52-week range, reflecting a prolonged downtrend through the year. Rs 212 to 216, the recent trading zone, is acting as near-term support, with a break lower opening the path toward fresh 52-week lows. On the upside, Rs 230 to 240 is the first resistance zone from recent price action. Disclosure: Palash Kag, Proprietor, Sarathi Research, SEBI Reg. No. INH000012740. No position held in Jio Financial Services Limited as on date. Views are educational and informational only, not financial advice or a recommendation to buy, sell or hold any security

See More